
Benjamin L. Lebron
Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )
| Most Active Art Unit | 1777 |
| Art Unit(s) | 1777, 1773 |
| Total Applications | 617 |
| Issued Applications | 402 |
| Pending Applications | 48 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15553125
[patent_doc_number] => 20200060974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
[patent_app_type] => utility
[patent_app_number] => 16/299214
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299214 | High surface-area lyophilized compositions comprising arsenic for oral administration in patients | Mar 11, 2019 | Issued |
Array
(
[id] => 14833117
[patent_doc_number] => 20190274959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/299675
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299675 | Pharmaceutical composition and administrations thereof | Mar 11, 2019 | Issued |
Array
(
[id] => 14743805
[patent_doc_number] => 20190255076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES
[patent_app_type] => utility
[patent_app_number] => 16/298818
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298818 | SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES | Mar 10, 2019 | Abandoned |
Array
(
[id] => 14531435
[patent_doc_number] => 20190201338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Compositions for Nanoemulsion Delivery Systems
[patent_app_type] => utility
[patent_app_number] => 16/298369
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298369 | Compositions for Nanoemulsion Delivery Systems | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16557114
[patent_doc_number] => 20210002262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/977019
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977019 | CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT | Mar 4, 2019 | Abandoned |
Array
(
[id] => 16681166
[patent_doc_number] => 10940626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Manufacturing of small film strips
[patent_app_type] => utility
[patent_app_number] => 16/290458
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290458 | Manufacturing of small film strips | Feb 28, 2019 | Issued |
Array
(
[id] => 14464753
[patent_doc_number] => 20190184016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/279129
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279129 | Ophthalmic composition | Feb 18, 2019 | Issued |
Array
(
[id] => 17200066
[patent_doc_number] => 20210340161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => NOVEL MAGNESIUM-SERINATE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/270123
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270123 | NOVEL MAGNESIUM-SERINATE COMPOUND AND USE THEREOF | Feb 11, 2019 | Pending |
Array
(
[id] => 19241092
[patent_doc_number] => 12011508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Methods and devices for reducing vascular smooth muscle cell proliferation
[patent_app_type] => utility
[patent_app_number] => 16/965078
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 20406
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965078
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965078 | Methods and devices for reducing vascular smooth muscle cell proliferation | Jan 31, 2019 | Issued |
Array
(
[id] => 14338475
[patent_doc_number] => 20190151210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD AND COMPOSITION FOR TREATING SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/253979
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253979 | METHOD AND COMPOSITION FOR TREATING SKIN CONDITIONS | Jan 21, 2019 | Abandoned |
Array
(
[id] => 14273837
[patent_doc_number] => 20190134203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => TOPICAL TETRACYCLINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/235964
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235964 | Topical tetracycline compositions | Dec 27, 2018 | Issued |
Array
(
[id] => 18477161
[patent_doc_number] => 11690886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Combination of a retinoid and an extract of
[patent_app_type] => utility
[patent_app_number] => 16/955729
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955729 | Combination of a retinoid and an extract of | Dec 19, 2018 | Issued |
Array
(
[id] => 16710213
[patent_doc_number] => 20210077360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => SOLID POWDER COSMETIC AND METHOD FOR PRODUCING SOLID POWDER COSMETIC
[patent_app_type] => utility
[patent_app_number] => 16/959550
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959550 | SOLID POWDER COSMETIC AND METHOD FOR PRODUCING SOLID POWDER COSMETIC | Dec 16, 2018 | Abandoned |
Array
(
[id] => 14210789
[patent_doc_number] => 20190117779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/220387
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220387 | NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION | Dec 13, 2018 | Pending |
Array
(
[id] => 14435173
[patent_doc_number] => 20190175458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => PERCARBONATE IN A WATER-SOLUBLE FILM FOR BLEACHING HUMAN HAIR
[patent_app_type] => utility
[patent_app_number] => 16/212265
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212265 | PERCARBONATE IN A WATER-SOLUBLE FILM FOR BLEACHING HUMAN HAIR | Dec 5, 2018 | Abandoned |
Array
(
[id] => 17618884
[patent_doc_number] => 11337909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation
[patent_app_type] => utility
[patent_app_number] => 16/768028
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13863
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768028 | Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation | Nov 28, 2018 | Issued |
Array
(
[id] => 14182607
[patent_doc_number] => 20190111008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHODS FOR STORING CYSTEAMINE FORMULATIONS AND RELATED METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/195481
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195481 | Methods for storing cysteamine formulations and related methods of treatment | Nov 18, 2018 | Issued |
Array
(
[id] => 14420089
[patent_doc_number] => 10314830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/176101
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 27942
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176101 | Pharmaceutical compositions | Oct 30, 2018 | Issued |
Array
(
[id] => 14040613
[patent_doc_number] => 20190076413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/173466
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16173466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/173466 | Pharmaceutical compositions | Oct 28, 2018 | Issued |
Array
(
[id] => 17858479
[patent_doc_number] => 11439617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Polymeric compositions of monomethyl fumarate and their use in treating relapsing remitting multiple sclerosis and psoriasis
[patent_app_type] => utility
[patent_app_number] => 16/756842
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 5751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756842 | Polymeric compositions of monomethyl fumarate and their use in treating relapsing remitting multiple sclerosis and psoriasis | Oct 15, 2018 | Issued |